CEACAM5 and neoplasm: In addition, SERPINB5 was demonstrated to be a biomarker for colorectal cancer that interacts with carcinoembryonic antigen (CEA), which has been already approved as a clinical marker [13], and was shown to increase tumor cell invasion and angiogenesis in human mammary epithelial cells [38].